{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:47:14Z","timestamp":1791902834670,"version":"4.3.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01DK031116"],"award-info":[{"award-number":["Z01DK031116"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10822-015-9858-z","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T09:54:29Z","timestamp":1437386069000},"page":"737-756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information"],"prefix":"10.1007","volume":"29","author":[{"given":"Silvia","family":"Paoletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Sabbadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"von K\u00fcgelgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Stra\u00dfburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younis","family":"Baqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"9858_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281\u2013341","journal-title":"Pharmacol Rev"},{"key":"9858_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0074-7696(04)40002-3","volume":"240","author":"G Burnstock","year":"2004","unstructured":"Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31\u2013304","journal-title":"Int Rev Cytol"},{"key":"9858_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/35051599","volume":"409","author":"G Hollopeter","year":"2001","unstructured":"Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202\u2013207","journal-title":"Nature"},{"key":"9858_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0031-6997(25)06665-7","volume":"43","author":"SM Hourani","year":"1991","unstructured":"Hourani SM, Cusack NJ (1991) Pharmacological receptors on blood platelets. Pharmacol Rev 43:243\u2013298","journal-title":"Pharmacol Rev"},{"key":"9858_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11302-011-9216-0","volume":"7","author":"KA Jacobson","year":"2011","unstructured":"Jacobson KA, Deflorian F, Mishra S, Costanzi S (2011) Pharmacochemistry of the platelet purinergic receptors. Purinergic Signal 7:305\u2013324","journal-title":"Purinergic Signal"},{"key":"9858_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1358\/dnp.2010.23.10.1506088","volume":"23","author":"B Debnath","year":"2010","unstructured":"Debnath B, Al-Mawsawi LQ, Neamati N (2010) Are we living in the end of the blockbuster drug era? Drug News Perspect 23:670\u2013684","journal-title":"Drug News Perspect"},{"issue":"14","key":"9858_CR7","doi-asserted-by":"publisher","first-page":"00175-2","DOI":"10.1016\/j.nbd.2014.06.011","volume":"S0969\u20139961","author":"G Horv\u00e1th","year":"2014","unstructured":"Horv\u00e1th G, G\u00f6l\u00f6ncs\u00e9r F, Cs\u00f6lle C, Kir\u00e1ly K, And\u00f3 RD, Baranyi M, Kov\u00e1nyi B, M\u00e1t\u00e9 Z, Hoffmann K, Algaier I, Baqi Y, M\u00fcller CE, Von K\u00fcgelgen I, Sperl\u00e1gh B (2014) Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiol Dis pii S0969\u20139961(14):00175-2. doi: 10.1016\/j.nbd.2014.06.011","journal-title":"Neurobiol Dis pii"},{"key":"9858_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-2003-40669","volume":"3","author":"JM Herbert","year":"2003","unstructured":"Herbert JM, Savi P (2003) P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med 3:113\u2013122","journal-title":"Semin Vasc Med"},{"key":"9858_CR9","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1021\/jm0493562","volume":"48","author":"G Cristalli","year":"2005","unstructured":"Cristalli G, Podda GM, Costanzi S, Lambertucci C, Lecchi A, Vittori S, Volpini R, Zighetti ML, Cattaneo M (2005) Effects of 5\u2032-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors. J Med Chem 48:2763\u20132766","journal-title":"J Med Chem"},{"key":"9858_CR10","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0960-894X(01)00313-4","volume":"11","author":"RM Scarborough","year":"2001","unstructured":"Scarborough RM, Laibelman AM, Clizbe LA, Fretto LJ, Conley PB, Reynolds EE, Sedlock DM, Jantzen H (2001) Novel tricyclic benzothiazolo[2,3-c]thiadiazine antagonists of the platelet ADP receptor (P2Y12). Bioorg Med Chem Lett 11:1805\u20131808","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR11","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.bmcl.2011.03.088","volume":"21","author":"P Bach","year":"2011","unstructured":"Bach P, Bostr\u00f6m J, Brickmann K, van Giezen JJ, Hovland R, Petersson AU, Ray A, Zetterberg FA (2011) novel series of piperazinyl-pyridine ureas as antagonists of the purinergic P2Y12 receptor. Bioorg Med Chem Lett 21:2877\u20132881","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ejmech.2013.04.007","volume":"65","author":"P Bach","year":"2013","unstructured":"Bach P, Bostr\u00f6m J, Brickmann K, van Giezen JJ, Groneberg RD, Harvey DM, O\u2019Sullivan M, Zetterberg F (2013) Synthesis, structure-property relationships and pharmacokinetic evaluation of ethyl 6-aminonicotinate sulfonylureas as antagonists of the P2Y12 receptor. Eur J Med Chem 65:360\u2013375","journal-title":"Eur J Med Chem"},{"key":"9858_CR13","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.4155\/fmc.13.171","volume":"5","author":"P Bach","year":"2013","unstructured":"Bach P, Bostr\u00f6m J, Brickmann K, Burgess LE, Clarke D, Groneberg RD, Harvey DM, Laird ER, O\u2019Sullivan M, Zetterberg F (2013) 5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptor. Future Med Chem 5:2037\u20132056","journal-title":"Future Med Chem"},{"key":"9858_CR14","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1021\/jm400820m","volume":"56","author":"P Bach","year":"2013","unstructured":"Bach P, Antonsson T, Bylund R, Bj\u00f6rkman JA, \u00d6sterlund K, Giordanetto F, van Giezen JJ, Andersen SM, Zachrisson H, Zetterberg F (2013) Lead optimization of ethyl 6-aminonicotinate acyl sulfonamides as antagonists of the P2Y12 receptor, separation of the antithrombotic effect and bleeding for candidate drug AZD1283. J Med Chem 56:7015\u20137024","journal-title":"J Med Chem"},{"key":"9858_CR15","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1021\/jm9003297","volume":"52","author":"Y Baqi","year":"2009","unstructured":"Baqi Y, Atzler K, K\u00f6se M, Gl\u00e4nzel M, M\u00fcller CE (2009) High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. J Med Chem 52:3784\u20133793","journal-title":"J Med Chem"},{"key":"9858_CR16","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.1016\/j.bmcl.2009.09.017","volume":"19","author":"JJ Parlow","year":"2009","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2009) Piperazinyl-glutamate-pyrimidines as potent P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 19:6148\u20136156","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR17","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1016\/j.bmcl.2009.06.075","volume":"19","author":"JJ Parlow","year":"2009","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2009) Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 19:4657\u20134663","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR18","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1021\/jm901518t","volume":"53","author":"JJ Parlow","year":"2010","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Harris PK, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2010) Piperazinyl glutamate pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. J Med Chem 53:2010\u20132037","journal-title":"J Med Chem"},{"key":"9858_CR19","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.bmcl.2009.12.110","volume":"20","author":"JJ Parlow","year":"2010","unstructured":"Parlow JJ, Burney MW, Case BL, Girard TJ, Hall KA, Harris PK, Hiebsch RR, Huff RM, Lachance RM, Mischke DA, Rapp SR, Woerndle RS, Ennis MD (2010) Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation. Bioorg Med Chem Lett 20:1388\u20131394","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR20","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1021\/jm300771j","volume":"55","author":"G Zech","year":"2012","unstructured":"Zech G, Hessler G, Evers A, Weiss T, Florian P, Just M, Czech J, Czechtizky W, G\u00f6rlitzer J, Ruf S, Kohlmann M, Nazar\u00e9 M (2012) Identification of high-affinity P2Y12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone. J Med Chem 55:8615\u20138629","journal-title":"J Med Chem"},{"key":"9858_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1021\/jm981072s","volume":"42","author":"AH Ingall","year":"1999","unstructured":"Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, Humphries RG, Leff P, Clegg JA, Smith JA, Tomlinson W (1999) Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. J Med Chem 42:213\u2013220","journal-title":"J Med Chem"},{"key":"9858_CR22","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1021\/jm020173u","volume":"45","author":"B Xu","year":"2002","unstructured":"Xu B, Stephens A, Kirschenheuter G, Greslin AF, Cheng X, Sennelo J, Cattaneo M, Zighetti ML, Chen A, Kim SA, Kim HS, Bischofberger N, Cook G, Jacobson KA (2002) Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation. J Med Chem 45:5694\u20135709","journal-title":"J Med Chem"},{"key":"9858_CR23","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1016\/j.bmcl.2007.07.057","volume":"17","author":"B Springthorpe","year":"2007","unstructured":"Springthorpe B, Bailey A, Barton P, Birkinshaw TN, Bonnert RV, Brown RC, Chapman D, Dixon J, Guile SD, Humphries RG, Hunt SF, Ince F, Ingall AH, Kirk IP, Leeson PD, Leff P, Lewis RJ, Martin BP, McGinnity DF, Mortimore MP, Paine SW, Pairaudeau G, Patel A, Rigby AJ, Riley RJ, Teobald BJ, Tomlinson W, Webborn PJ, Willis PA (2007) From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis. Bioorg Med Chem Lett 17:6013\u20136018","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/cmdc.200700310","volume":"3","author":"H Ye","year":"2008","unstructured":"Ye H, Chen C, Zhang HC, Haertlein B, Parry TJ, Damiano BP, Maryanoff BE (2008) Carba-nucleosides as potent antagonists of the adenosine 5\u2032-diphosphate (ADP) purinergic receptor (P2Y12) on human platelets. Chem Med Chem 3:732\u2013736","journal-title":"Chem Med Chem"},{"key":"9858_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/jm701348d","volume":"51","author":"JG Douglass","year":"2008","unstructured":"Douglass JG, Patel RI, Yerxa BR, Shaver SR, Watson PS, Bednarski K, Plourde R, Redick CC, Brubaker K, Jones AC, Boyer JL (2008) Lipophilic modifications to dinucleoside polyphosphates and nucleotides that confer antagonist properties at the platelet P2Y12 receptor. J Med Chem 51:1007\u20131025","journal-title":"J Med Chem"},{"key":"9858_CR26","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.bmcl.2008.01.038","volume":"18","author":"JG Douglass","year":"2008","unstructured":"Douglass JG, deCamp JB, Fulcher EH, Jones W, Mahanty S, Morgan A, Smirnov D, Boyer JL, Watson PS (2008) Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation. Bioorg Med Chem Lett 18:2167\u20132171","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR27","doi-asserted-by":"publisher","first-page":"5919","DOI":"10.1016\/j.bmcl.2009.08.059","volume":"19","author":"SW Kortum","year":"2009","unstructured":"Kortum SW, Lachance RM, Schweitzer BA, Yalamanchili G, Rahman H, Ennis MD, Huff RM, TenBrink RE (2009) Thienopyrimidine-based P2Y12 platelet aggregation inhibitors. Bioorg Med Chem Lett 19:5919\u20135923","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bmcl.2013.11.055","volume":"24","author":"W Tu","year":"2014","unstructured":"Tu W, Fan J, Zhang H, Xu G, Liu Z, Qu J, Yang F, Zhang L, Luan T, Yuan J, Gong A, Feng J, Sun P, Dong Q (2014) Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists. Bioorg Med Chem Lett 24:141\u2013146","journal-title":"Bioorg Med Chem Lett"},{"key":"9858_CR29","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1073\/pnas.89.6.2370","volume":"89","author":"PC Zamecnik","year":"1992","unstructured":"Zamecnik PC, Kim B, Gao MJ, Taylor G, Blackburn GM (1992) Analogues of diadenosine 5\u2032,5\u2032\u2032\u2032-P1, P4-tetraphosphate (Ap4A) as potential anti-platelet-aggregation agents. Proc Natl Acad Sci USA 89:2370\u20132373","journal-title":"Proc Natl Acad Sci USA"},{"key":"9858_CR30","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1111\/jth.12035","volume":"10","author":"H Chang","year":"2012","unstructured":"Chang H, Yanachkov IB, Dix EJ, Li YF, Barnard MR, Wright GE, Michelson AD, Frelinger AL 3rd (2012) Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation. J Thromb Haemost 10:2573\u20132580","journal-title":"J Thromb Haemost"},{"key":"9858_CR31","doi-asserted-by":"publisher","first-page":"e94780","DOI":"10.1371\/journal.pone.0094780","volume":"9","author":"H Chang","year":"2014","unstructured":"Chang H, Yanachkov IB, Dix EJ, Yanachkova M, Li Y, Barnard MR, Wright GE, Michelson AD, Frelinger AL 3rd (2014) Antiplatelet activity, P2Y1 and P2Y12 inhibition, and metabolism in plasma of stereoisomers of diadenosine 5\u2032,5\u2032\u2032\u2032-P1, P4-dithio-P2, P3-chloromethylenetetraphosphate. PLoS ONE 9:e94780","journal-title":"PLoS ONE"},{"key":"9858_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","volume":"27","author":"S Husted","year":"2009","unstructured":"Husted S, van Giezen JJ (2009) Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist. Cardiovasc Ther 27:259\u2013274","journal-title":"Cardiovasc Ther"},{"key":"9858_CR33","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1538-7836.2004.00926.x","volume":"2","author":"G Kauffenstein","year":"2004","unstructured":"Kauffenstein G, Hechler B, Cazenave JP, Gachet C (2004) Adenine triphosphate nucleotides are antagonists at the P2Y receptor. J Thromb Haemost 2:1980\u20131988","journal-title":"J Thromb Haemost"},{"key":"9858_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/mol.112.082198","volume":"83","author":"P Schmidt","year":"2013","unstructured":"Schmidt P, Ritscher L, Dong EN, Hermsdorf T, C\u00f6ster M, Wittkopf D, Meiler J, Sch\u00f6neberg T (2013) Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12. Mol Pharmacol 83:256\u2013266","journal-title":"Mol Pharmacol"},{"key":"9858_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.thromres.2009.11.006","volume":"125","author":"H Chang","year":"2010","unstructured":"Chang H, Yanachkov IB, Michelson AD, Li Y, Barnard MR, Wright GE, Frelinger AL III (2010) Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptors. Thromb Res 125:159\u2013165","journal-title":"Thromb Res"},{"key":"9858_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10822-011-9423-3","volume":"25","author":"F Deflorian","year":"2011","unstructured":"Deflorian F, Jacobson KA (2011) Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor. J Comput Aided Mol Des 25:329\u2013338","journal-title":"J Comput Aided Mol Des"},{"key":"9858_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature13288","volume":"509","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, M\u00fcller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q (2014) Agonist-bound structure of the human P2Y12 receptor. Nature 509:119\u2013122","journal-title":"Nature"},{"key":"9858_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature13083","volume":"509","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, M\u00fcller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q (2014) Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509:115\u2013118","journal-title":"Nature"},{"key":"9858_CR39","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1124\/jpet.104.068650","volume":"311","author":"M Chhatriwala","year":"2004","unstructured":"Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311:1038\u20131043","journal-title":"J Pharmacol Exp Ther"},{"key":"9858_CR40","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.bcp.2008.08.029","volume":"76","author":"K Hoffmann","year":"2008","unstructured":"Hoffmann K, Sixel U, Di Pasquale F, von K\u00fcgelgen I (2008) Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y12-receptor. Biochem Pharmacol 76:1201\u20131213","journal-title":"Biochem Pharmacol"},{"key":"9858_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1742-4658.2011.08410.x","volume":"279","author":"V Ignatovica","year":"2012","unstructured":"Ignatovica V, Megnis K, Lapins M, Schioth HB, Klovins J (2012) Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system. FEBS J 279:180\u2013191","journal-title":"FEBS J"},{"key":"9858_CR42","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shaw DE, Shelley M, Perry JK, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749","journal-title":"J Med Chem"},{"key":"9858_CR43","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1021\/jm500588w","volume":"57","author":"C Boldron","year":"2014","unstructured":"Boldron C, Besse A, Bordes MF, Tissandi\u00e9 S, Yvon X, Gau B, Badorc A, Rousseaux T, Barr\u00e9 G, Meneyrol J, Zech G, Nazare M, Fossey V, Pflieger AM, Bonnet-Lignon S, Millet L, Briot C, Dol F, H\u00e9rault JP, Savi P, Lassalle G, Delesque N, Herbert JM, Bono F (2014) N-[6-(4-Butanoyl-5-methyl-1H-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1H-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist. J Med Chem 57:7293\u20137316","journal-title":"J Med Chem"},{"key":"9858_CR44","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1124\/jpet.109.156687","volume":"331","author":"K Hoffmann","year":"2009","unstructured":"Hoffmann K, Baqi Y, Morena MS, Gl\u00e4nzel M, M\u00fcller CE, von K\u00fcgelgen I (2009) Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor. J Pharmacol Exp Ther 331:648\u2013655","journal-title":"J Pharmacol Exp Ther"},{"key":"9858_CR45","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1111\/jth.12719","volume":"12","author":"K Hoffmann","year":"2014","unstructured":"Hoffmann K, Lutz DA, Stra\u00dfburger J, Baqi Y, M\u00fcller CE, von K\u00fcgelgen I (2014) Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12-receptor. J Thromb Haemost 12:1898\u20131905","journal-title":"J Thromb Haemost"},{"key":"9858_CR46","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1124\/mol.114.095711","volume":"88","author":"KA Jacobson","year":"2015","unstructured":"Jacobson KA, Paoletta S, Katritch V, Wu B, Zhao Q, Stevens RC, Kiselev E (2015) Nucleotides acting at P2Y receptors: connecting structure and function. Mol Pharmacol 88:220\u2013230","journal-title":"Mol Pharmacol"},{"key":"9858_CR47","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman W, Day T, Jacobson MP, Friesner RA, Farid R (2006) Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49:534\u2013553","journal-title":"J Med Chem"},{"key":"9858_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1021\/ci400766b","volume":"54","author":"D Sabbadin","year":"2014","unstructured":"Sabbadin D, Moro S (2014) Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale. J Comp Inf Mod 54:372\u2013376","journal-title":"J Comp Inf Mod"},{"key":"9858_CR49","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1021\/ci500397y","volume":"54","author":"D Sabbadin","year":"2014","unstructured":"Sabbadin D, Ciancetta A, Moro S (2014) Perturbation of fluid dynamics properties of water molecules during G protein-coupled receptor-ligand recognition: the human A2A adenosine receptor as a key study. J Chem Inf Model 54:2846\u20132855","journal-title":"J Chem Inf Model"},{"key":"9858_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12900-014-0019-8","volume":"14","author":"O Carugo","year":"2014","unstructured":"Carugo O (2014) Buried chloride stereochemistry in the protein data bank. BMC Struct Biol 14:19","journal-title":"BMC Struct Biol"},{"key":"9858_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","volume":"25","author":"JA Ballesteros","year":"1995","unstructured":"Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G protein-coupled receptors. Methods Neurosci 25:366\u2013428","journal-title":"Methods Neurosci"},{"key":"9858_CR52","volume-title":"Schr\u00f6dinger","author":"Schr\u00f6dinger Suite","year":"2014","unstructured":"Suite Schr\u00f6dinger (2014) Schr\u00f6dinger. LLC, New York, NY"},{"issue":"33\u201338","key":"9858_CR53","first-page":"27","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph\u00a014(33\u201338):27\u201328","journal-title":"J Mol Graph"},{"key":"9858_CR54","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcc.21688","volume":"32","author":"M Seeber","year":"2011","unstructured":"Seeber M, Felline A, Raimondi F, Muff S, Friedman R, Rao F, Caflisch A, Fanelli F (2011) Wordom: a user-friendly program for the analysis of molecular structures, trajectories, and free energy surfaces. J Comput Chem 32:1183\u20131194","journal-title":"J Comput Chem"},{"key":"9858_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W","volume":"56","author":"AD MacKerell Jr","year":"2000","unstructured":"MacKerell AD Jr, Banavali N, Foloppe N (2000) Development and current status of the CHARMM force field for nucleic acids. Biopolymers 56:257\u2013265","journal-title":"Biopolymers"},{"key":"9858_CR56","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kal\u00e9 L, Schulten K (2005) Scalable molecular dynamics with NAMD. J Comput Chem 26:1781\u20131802","journal-title":"J Comput Chem"},{"key":"9858_CR57","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.thromres.2008.04.009","volume":"122","author":"JM Post","year":"2008","unstructured":"Post JM, Alexander S, Wang YX, Vincelette J, Vergona R, Kent L, Bryant J, Sullivan ME, Dole WP, Morser J, Subramanyam B (2008) Novel P2Y12 adenosine diphosphate receptor antagonists for inhibition of platelet aggregation (II): pharmacodynamic and pharmacokinetic characterization. Thromb Res 122:533\u2013540","journal-title":"Thromb Res"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-015-9858-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9858-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-015-9858-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:37:43Z","timestamp":1748522263000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-015-9858-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["9858"],"URL":"https:\/\/doi.org\/10.1007\/s10822-015-9858-z","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]},"assertion":[{"value":"7 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}